WisdomTree Trust - WisdomTree BioRevolution Fund EBIT

As of the most recent data (April 2026), WDNA shows a EBIT of $550M. That compares with $450M in the prior-year period — up 21.4% year over year. That is below the Finance sector average of $300B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, WDNA's EBIT is now $550M (was $450M) — a 21.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether WisdomTree Trust - WisdomTree BioRevolution Fund is outperforming or lagging.

The Finance sector average EBIT is about $300B. WisdomTree Trust - WisdomTree BioRevolution Fund is at $550M, which is lower that average. That is roughly 99.8% below the sector mean. Use the comparison chart on this page to see how WDNA stacks up against individual peers as well.

Tracking WDNA's ebit over time shows whether WisdomTree Trust - WisdomTree BioRevolution Fund is scaling, shrinking, or reshaping that part of the business. The current reading is $550M That compares with $450M in the prior-year period — up 21.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has WisdomTree Trust - WisdomTree BioRevolution Fund's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $550M) with ownership activity and broader fundamentals.